One Line Pitch: Aptamer Based Nano- Biosensors for rapid detection of colon, prostate and breast cancer
Business Summary: APTAS BioTech Inc. designs and manufacture Aptamer Based Nano- Biosensors for rapid detection of biomarkers associated with certain cancers. The company’s initial product is designed for the rapid diagnosis of colon cancer with the aim to enhance current protocols with a quicker and more cost-effective diagnostic testing solution. The product will not only be used for an earlier diagnosis of metastasis Colon Cancer but will also be used for monitoring progression and recurrence. A final research and development objective is to also provide early prediction of therapeutic efficacy and drug resistance based on a patient’s specific biomarkers. Future applications will include Prostate and Breast Cancer.
Sector: Life Sciences